Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.

Ana AntunQi ZhangShalender BhasinAndrew BradlynW Dana FlandersDarios GetahunTimothy L LashRebecca NashDouglas RoblinMichael J SilverbergVin TangprichaSuma VupputuriMichael Goodman

Published in: Journal of the Endocrine Society (2020)

Our results support previous recommendations that hematological parameters of transgender people receiving HT should be interpreted based on their affirmed gender, rather than their sex documented at birth. The clinical significance of erythrocytosis following testosterone therapy, as well as anemia following feminizing HT, requires further investigation.

Keyphrases

hiv testing
chronic kidney disease
mental health
replacement therapy
stem cells
clinical practice
pregnant women
men who have sex with men
bone marrow
cell therapy
smoking cessation